Research LetterOutcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention
Section snippets
Conflicts of interest
The authors have nothing to disclose.
References (3)
- et al.
EAU guidelines on penile cancer: 2014 update
Eur Urol
(2015)
There are more references available in the full text version of this article.
Cited by (14)
Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: A retrospective multicenter study
2019, Urologic Oncology: Seminars and Original InvestigationsCitation Excerpt :The detrimental HR of neoadjuvant chemotherapy from multivariable models is plausible, because patients with high-risk disease on pathological examination do usually worse than those who are chemonaive and harbor a potentially chemosensitive disease at the time of relapse. This hypothesis was proven in penile cancer patients by the present authors in previous studies [21]. Conversely, the detrimental effect of neoadjuvant chemotherapy that is observed from Kaplan-Meier analyses means that other negative prognostic factors are unaccounted for retrospectively.
Systemic treatment of penile cancer: New concepts? New achievements?
2023, Tumor Diagnostik und TherapieSystemic treatment of penile cancer: New concepts? New achievements?
2023, Aktuelle UrologieUrological Cancers and Kidney Transplantation: a Literature Review
2021, Current Urology ReportsPenile cancer
2021, Nature Reviews Disease PrimersPenile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy
2021, Current Urology Reports
© 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.